MRSA (methicillin resistant Staphylococcus aureus) continues to be a significant problem for many hospitals. MRSA infection results in increased morbidity, mortality and raises overall treatment costs.
Bioquell's hydrogen peroxide vapor (HPV) technology can help bring MRSA outbreaks or clusters under control quickly, resulting in reduced transmission and improved patient throughput leading to substantial cost savings.
> Explore our methicillin-resistant Staphylococcus aureus (MRSA) microbiology area.
Each MRSA Eradication Program is tailored to an individual hospital's specific needs. Bioquell works closely with hospital infection control teams to integrate Bioquell HPV technology with existing MRSA remediation protocols or infection control bundles. A typical program consists of elements of Bioquell's core service offerings:
What evidence is there that Bioquell can suppress MRSA outbreaks?
Bioquell has been used frequently in MRSA suppression. There are two published examples of the successful use of Bioquell to control outbreaks of MRSA on surgical wards in the UK (Jeanes A, Rao G, Osman M, Merrick P. Eradication of persistent environmental MRSA. J Hosp Infect 2005; 61: 85-86; Dryden M, Parnaby R, Dailly S et al. Hydrogen peroxide vapour decontamination in the control of a polyclonal meticillin-resistant Staphylococcus aureus outbreak on a surgical ward. J Hosp Infect 2008; 68: 190-192).